April 7, 2026
Saladax Biomedical to Expand International Access to Drug Level Testing for Psychiatry and Oncology
Bethlehem, PA, April 07, 2026 (GLOBE NEWSWIRE) -- Saladax Biomedical, Inc., a leader in therapeutic…
March 15, 2022
Saladax Biomedical, Inc. Announces Global Distribution Agreement With Beckman Coulter, Inc. for Antipsychotic Drug Tests
BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (Saladax) is pleased to announce the signing of a global…
November 30, 2021
CEO Sal Salamone Honored with International Award for his Work in the Life Sciences
Article By Nicole Radzievich Mertz, originally posted at lehighvalley.org Dr. Salvatore Salamone, founder of Saladax…
November 22, 2021
Saladax Biomedical and HLS Therapeutics Strengthen Partnership With an Exclusive Distribution Agreement for Canada
BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc (Saladax) is pleased to announce an exclusive distribution agreement with…
September 27, 2021
Saladax Biomedical Announces Salvatore J. Salamone, Ph.D. Received the Prestigious Dr. C.E. Pippenger Award
BETHLEHEM, Pa.--(BUSINESS WIRE)--Salvatore J. Salamone, Ph.D. received the prestigious Dr. C.E. Pippenger Award at the…
October 14, 2017
Saladax is Awarded “Best Poster Presentation” for Study on Individualized Dosing of Paclitaxel
Saladax Biomedical, Inc., recently presented a study on the value of adjusting paclitaxel doses. The…
October 28, 2016
Salvatore J. Salamone, Ph.D., Founder and CEO of Saladax Biomedical, Inc. Inducted into the New Jersey Inventors Hall of Fame
Saladax Biomedical, Inc., the leader in developing oncology diagnostics that increase the impact of personalized…
